› Belgium
Burden of salmonellosis, campylobacteriosis and listeriosis: a time series analysis, Belgium, 2012 to 2020
Maertens de Noordhout C, Devleesschauwer B, Haagsma JA, Havelaar AH, Bertrand S, Vandenberg O, Quoilin S, Brandt PT, Speybroeck N.
Euro Surveill. 2017; 22:30615
Belgium ⁃ Burden ⁃ Foodborne disease
Maertens de Noordhout C, Devleesschauwer B, Haagsma JA, Havelaar AH, Bertrand S, Vandenberg O, Quoilin S, Brandt PT, Speybroeck N.
Euro Surveill. 2017; 22:30615
Belgium ⁃ Burden ⁃ Foodborne disease
Intake of fat-soluble vitamins in the Belgian population: adequacy and contribution of foods, fortified foods and supplements
Moyersoen I, Devleesschauwer B, Dekkers A, De Ridder K, Tafforeau J, Van Camp J, Van Oyen H, Lachat C.
Nutrients. 2017; 9:860
Belgium
Moyersoen I, Devleesschauwer B, Dekkers A, De Ridder K, Tafforeau J, Van Camp J, Van Oyen H, Lachat C.
Nutrients. 2017; 9:860
Belgium
The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium
Geebelen L, Lernout T, Kabamba-Mukadi B, Saegeman V, Sprong H, Van Gucht S, Beutels P, Speybroeck N, Tersago K.
Arch Public Health. 2017; 75:42
Belgium ⁃ Burden
Geebelen L, Lernout T, Kabamba-Mukadi B, Saegeman V, Sprong H, Van Gucht S, Beutels P, Speybroeck N, Tersago K.
Arch Public Health. 2017; 75:42
Belgium ⁃ Burden
Public health impact of congenital toxoplasmosis and cytomegalovirus infection in Belgium, 2013: a systematic review and data synthesis
Smit GSA, Padalko E, Van Acker J, Hens N, Dorny P, Speybroeck N, Devleesschauwer B.
Clin Infect Dis. 2017; 65:661-668
Belgium ⁃ Burden ⁃ Foodborne disease
Smit GSA, Padalko E, Van Acker J, Hens N, Dorny P, Speybroeck N, Devleesschauwer B.
Clin Infect Dis. 2017; 65:661-668
Belgium ⁃ Burden ⁃ Foodborne disease
Trends in educational inequalities in premature mortality in Belgium between the 1990s and the 2000s: the contribution of specific causes of deaths
Renard F, Gadeyne S, Devleesschauwer B, Tafforeau J, Deboosere P.
J Epidemiol Community Health. 2017; 71:371-380
Belgium ⁃ Burden ⁃ Health inequalities
Renard F, Gadeyne S, Devleesschauwer B, Tafforeau J, Deboosere P.
J Epidemiol Community Health. 2017; 71:371-380
Belgium ⁃ Burden ⁃ Health inequalities
Cost-effectiveness and budget effect analysis of a population-based skin cancer screening
Pil L, Hoorens I, Vossaert K, Kruse V, Tromme I, Speybroeck N, Annemans L, Brochez L.
JAMA Dermatol. 2017; 153:147-153
Belgium ⁃ Cost-effectiveness
Pil L, Hoorens I, Vossaert K, Kruse V, Tromme I, Speybroeck N, Annemans L, Brochez L.
JAMA Dermatol. 2017; 153:147-153
Belgium ⁃ Cost-effectiveness
Cost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium
Smit GSA, Apers L, Arrazole de Onate W, Beutels P, Dorny P, Forier A-M, Janssens K, Macq J, Mak R, Schol S, Wildemeersch D, Speybroeck N, Devleesschauwer B.
Bull World Health Organ. 2017; 95:27-35
Belgium ⁃ Cost-effectiveness
Smit GSA, Apers L, Arrazole de Onate W, Beutels P, Dorny P, Forier A-M, Janssens K, Macq J, Mak R, Schol S, Wildemeersch D, Speybroeck N, Devleesschauwer B.
Bull World Health Organ. 2017; 95:27-35
Belgium ⁃ Cost-effectiveness
Burden of skin cancer in Belgium and cost-effectiveness of primary prevention by reducing ultraviolet exposure
Pil L, Hoorens I, Vossaert K, Kruse V, Tromme I, Speybroeck N, Brochez L, Annemans L.
Prev Med. 2017; 93:177-182
Belgium ⁃ Burden ⁃ Cost-effectiveness
Pil L, Hoorens I, Vossaert K, Kruse V, Tromme I, Speybroeck N, Brochez L, Annemans L.
Prev Med. 2017; 93:177-182
Belgium ⁃ Burden ⁃ Cost-effectiveness
Cost-effectiveness analysis in melanoma detection: a transition model applied to dermoscopy
Tromme I, Legrand C, Devleesschauwer B, Leiter U, Suciu S, Eggermont A, Sacré L, Baurain J-F, Thomas L, Beutels P, Speybroeck N.
Eur J Cancer. 2016; 67:38-45
Belgium ⁃ Cost-effectiveness
Tromme I, Legrand C, Devleesschauwer B, Leiter U, Suciu S, Eggermont A, Sacré L, Baurain J-F, Thomas L, Beutels P, Speybroeck N.
Eur J Cancer. 2016; 67:38-45
Belgium ⁃ Cost-effectiveness
Comorbidities and factors associated with central nervous system infections and death in non-perinatal listeriosis: a clinical case series
Maertens de Noordhout C, Devleesschauwer B, Maertens de Noordhout A, Blocher J, Haagsma JA, Havelaar AH, Speybroeck N.
BMC Infect Dis. 2016; 16:256
Belgium ⁃ Burden ⁃ Foodborne disease
Maertens de Noordhout C, Devleesschauwer B, Maertens de Noordhout A, Blocher J, Haagsma JA, Havelaar AH, Speybroeck N.
BMC Infect Dis. 2016; 16:256
Belgium ⁃ Burden ⁃ Foodborne disease
Melanoma burden by melanoma stage: assessment through a disease transition model
Tromme I, Legrand C, Devleesschauwer B, Leiter U, Suciu S, Eggermont A, Francart J, Calay F, Haagsma JA, Baurain J, Thomas L, Beutels P, Speybroeck N.
Eur J Cancer. 2016; 53:33-41
Belgium ⁃ Burden
Tromme I, Legrand C, Devleesschauwer B, Leiter U, Suciu S, Eggermont A, Francart J, Calay F, Haagsma JA, Baurain J, Thomas L, Beutels P, Speybroeck N.
Eur J Cancer. 2016; 53:33-41
Belgium ⁃ Burden
Health related quality of life in melanoma patients expressed as utilities and disability weights
Tromme I, Devleesschauwer B, Beutels P, Richez P, Leroy A, Baurain J-F, Cornelis F, Bertrand C, Legrand N, Degueldre J, Thomas L, Legrand C, Lambert J, Haagsma J, Speybroeck N.
Br J Dermatol. 2014; 171:1443-1450
Belgium ⁃ Disability weights
Tromme I, Devleesschauwer B, Beutels P, Richez P, Leroy A, Baurain J-F, Cornelis F, Bertrand C, Legrand N, Degueldre J, Thomas L, Legrand C, Lambert J, Haagsma J, Speybroeck N.
Br J Dermatol. 2014; 171:1443-1450
Belgium ⁃ Disability weights
Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints
Devleesschauwer B, Maertens de Noordhout C, Smit GSA, Duchateau L, Dorny P, Stein C, Van Oyen H, Speybroeck N.
BMC Public Health. 2014; 14:1196
Belgium ⁃ Burden
Devleesschauwer B, Maertens de Noordhout C, Smit GSA, Duchateau L, Dorny P, Stein C, Van Oyen H, Speybroeck N.
BMC Public Health. 2014; 14:1196
Belgium ⁃ Burden
Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a Belgian study of patients with a single or a small number of atypical nevi
Tromme I, Devleesschauwer B, Beutels P, Richez P, Praet N, Sacré L, Marot L, Van Eeckhout P, Theate I, Baurain JF, Lambert J, Legrand C, Thomas L, Speybroeck N.
PLOS ONE. 2014; 9:e109339
Belgium ⁃ Cost-effectiveness
Tromme I, Devleesschauwer B, Beutels P, Richez P, Praet N, Sacré L, Marot L, Van Eeckhout P, Theate I, Baurain JF, Lambert J, Legrand C, Thomas L, Speybroeck N.
PLOS ONE. 2014; 9:e109339
Belgium ⁃ Cost-effectiveness
The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease
Henrard S, Devleesschauwer B, Beutels P, Callens M, De Smet F, Hermans C, Speybroeck N.
Orphanet J Rare Dis. 2014; 9:39
Belgium ⁃ Burden
Henrard S, Devleesschauwer B, Beutels P, Callens M, De Smet F, Hermans C, Speybroeck N.
Orphanet J Rare Dis. 2014; 9:39
Belgium ⁃ Burden
Evidence-based semi-quantitative methodology for prioritization of food-borne zoonoses
Cardoen S, Van Huffel X, Berkvens D, Quoilin S, Ducoffre G, Saegerman C, Speybroeck N, Imberechts H, Herman L, Ducatelle R, Dierick K.
Foodborne Pathog Dis. 2009; 6:1083-1096
Belgium ⁃ Foodborne disease ⁃ Risk ranking
Cardoen S, Van Huffel X, Berkvens D, Quoilin S, Ducoffre G, Saegerman C, Speybroeck N, Imberechts H, Herman L, Ducatelle R, Dierick K.
Foodborne Pathog Dis. 2009; 6:1083-1096
Belgium ⁃ Foodborne disease ⁃ Risk ranking